dc.contributor.author
Ihl, Thomas
dc.contributor.author
Kadas, Ella M.
dc.contributor.author
Oberwahrenbrock, Timm
dc.contributor.author
Endres, Matthias
dc.contributor.author
Klockgether, Thomas
dc.contributor.author
Schroeter, Jan
dc.contributor.author
Brandt, Alexander U.
dc.contributor.author
Paul, Friedemann
dc.contributor.author
Minnerop, Martina
dc.contributor.author
Doss, Sarah
dc.contributor.author
Schmitz-Hübsch, Tanja
dc.contributor.author
Zimmermann, Hanna G.
dc.date.accessioned
2022-10-18T10:43:22Z
dc.date.available
2022-10-18T10:43:22Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36576
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36289
dc.description.abstract
Spinocerebellar ataxia type 14 (SCA-PRKCG, formerly SCA14) is a rare, slowly progressive disorder caused by conventional mutations in protein kinase Cγ (PKCγ). The disease usually manifests with ataxia, but previous reports suggested PRKCG variants in retinal pathology. To systematically investigate for the first time visual function and retinal morphology in patients with SCA-PRKCG. Seventeen patients with PRKCG variants and 17 healthy controls were prospectively recruited, of which 12 genetically confirmed SCA-PRKCG patients and 14 matched controls were analyzed. We enquired a structured history for visual symptoms. Vision-related quality of life was obtained with the National Eye Institute Visual Function Questionnaire (NEI-VFQ) including the Neuro-Ophthalmic Supplement (NOS). Participants underwent testing of visual acuity, contrast sensitivity, visual fields, and retinal morphology with optical coherence tomography (OCT). Measurements of the SCA-PRKCG group were analyzed for their association with clinical parameters (ataxia rating and disease duration). SCA-PRKCG patients rate their vision-related quality of life in NEI-VFQ significantly worse than controls. Furthermore, binocular visual acuity and contrast sensitivity were worse in SCA-PRKCG patients compared with controls. Despite this, none of the OCT measurements differed between groups. NEI-VFQ and NOS composite scores were related to ataxia severity. Additionally, we describe one patient with a genetic variant of uncertain significance in the catalytic domain of PKCγ who, unlike all confirmed SCA-PRKCG, presented with a clinically silent epitheliopathy. SCA-PRKCG patients had reduced binocular vision and vision-related quality of life. Since no structural retinal damage was found, the pathomechanism of these findings remains unclear.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Spinocerebellar ataxias
en
dc.subject
Protein kinase C gamma
en
dc.subject
Optical coherence tomography
en
dc.subject
Vision disorders
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Investigation of Visual System Involvement in Spinocerebellar Ataxia Type 14
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s12311-020-01130-w
dcterms.bibliographicCitation.journaltitle
The Cerebellum
dcterms.bibliographicCitation.number
4
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
469
dcterms.bibliographicCitation.pageend
482
dcterms.bibliographicCitation.volume
19
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
32338350
dcterms.isPartOf.issn
1473-4222
dcterms.isPartOf.eissn
1473-4230